Effect of Hulba in reducing the size of Uterine Fibroid
Phase 2
- Conditions
- Health Condition 1: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2024/05/066898
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Size of uterine fibroid ranging from 1-6cm documented on USG with or without symptoms
Exclusion Criteria
Pregnancy, Severe symptomatic uterine fibroid and associated endometriosis or adenomyosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in size of uterine fibroid on USG pelvisTimepoint: At baseline and after 3 months
- Secondary Outcome Measures
Name Time Method Reduction in symptomsTimepoint: At baseline, 1 month, 2 months & 3 months